Quantcast

Latest Dana-Farber Cancer Institute Stories

2014-07-25 23:03:18

Harvard Neuro-Oncologist presents latest brain tumor research and treatment options at American Brain Tumor Association’s annual conference. Chicago, IL (PRWEB) July 25, 2014 Progress in understanding the molecular genetics of brain tumors has ushered in a new era of promising brain tumor treatments, according to Patrick Wen, MD, professor of neurology, Harvard Medical School, director of the Center for Neuro-Oncology, Dana-Farber Cancer Institute. At the American Brain Tumor...

2014-07-14 12:48:10

Dana-Farber Cancer Institute Study pinpoints a molecular cause of cachexia, and hints at a potential treatment New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute. Many strategies have been tried to reverse the condition, which may cause such frailty that patients can't endure potentially...

2014-06-24 08:30:32

CAMBRIDGE, Mass., June 24, 2014 /PRNewswire/ -- Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber's Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen's lung cancer discovery pipeline. "We are...

2014-06-16 08:28:29

Company continues to engage leading cancer treatment centers to investigate non-invasive methods of cancer mutation detection in order to advance patient care SAN DIEGO, June 16, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time...

2014-05-28 08:32:11

National Nonprofit Organization Contributes $1.2 Million to Support Pediatric Cancer Research Projects Nationwide ATLANTA, May 28, 2014 /PRNewswire-USNewswire/ -- Rally Foundation for Childhood Cancer Research (Rally), a national nonprofit organization, today announced that it is awarding more than $1.2 million to 30 hospitals across the country as part of its annual funding allocation for 2014. "Rally enables cutting-edge research to continue what would otherwise not be possible...

2014-04-25 08:27:52

NEW YORK, April 25, 2014 /PRNewswire/ -- Uniting Against Lung Cancer (UALC), a nonprofit dedicated to funding innovative research and raising awareness for lung cancer, announces that it has achieved a new level of funding this year, committing more than $1.5 million in lung cancer research grants to premier medical and research institutions across the country. This contribution brings UALC's total funding for lung cancer research grants to a total of $11.5 million. Lung cancer is...

2014-04-24 10:48:03

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene. The extraordinary finding comes from a multi-institutional team that analyzed data and other material from two long-term studies involving nearly 128,000 participants. The researchers found that individuals whose colons have high levels of a specific gene product...

2014-04-21 13:46:28

Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions. In a study posted online today by the journal Nature Genetics, the researchers track the genetic chain of events that links a chromosomal abnormality in Down syndrome to the cellular havoc...

2014-04-18 12:35:28

A Dana-Farber/Boston Children's and VA Hospital/University of South Florida team created the antiviral therapy, which harnesses the power of stapled peptide and nanoparticle technologies to thwart the respiratory virus New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly. Despite a wide range of anti-RSV efforts, there are no vaccines or drugs on the...

2014-04-07 16:05:15

Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and McGill University. The findings identify potential new targets for drug treatments. The new research could help physicians choose targeted agents with a better chance of combating pediatric high-grade astrocytomas, which are extremely difficult to...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related